ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,867Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 41

$500K Total Retail Price of All Prescriptions

Rank: 13 out of 41

447 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 447 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

5% of this provider’s 447 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 4,542 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 60%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
OMEPRAZOLE 341 216 1 7
SPIRIVA 313 208 2 1
PROAIR HFA 295 184 3 3
FUROSEMIDE 245 158 4 9
PREDNISONE 235 167 5 4
ADVAIR HFA 219 137 10 6 45
ZOLPIDEM TARTRATE 184 102 7 23
ADVAIR DISKUS 156 130 8 2
METOPROLOL TARTRATE 147 103 9 24
SIMVASTATIN 147 99 9 15
AMLODIPINE BESYLATE 142 100 11 16
LISINOPRIL 137 103 12 17
HYDROCODONE-ACETAMINOPHEN 134 107 S3 13 13
LEVOTHYROXINE SODIUM 120 94 14 12
AMOX TR-POTASSIUM CLAVULANATE 115 79 15 63
LEVOFLOXACIN 109 73 16 28
VENTOLIN HFA 93 60 17 18
RANITIDINE HCL 91 42 18 39
TRAMADOL HCL 82 56 19 41
NEXIUM 80 44 20 26
MELOXICAM 76 67 21 87
SINGULAIR 75 55 22 6
METFORMIN HCL 74 36 23 20
CIPROFLOXACIN HCL 74 43 23 72
GABAPENTIN 72 65 25 29
WARFARIN SODIUM 72 44 25 22
KLOR-CON M20 71 40 27 52
ISOSORBIDE MONONITRATE ER 71 44 27 35
METOPROLOL SUCCINATE 68 50 29 37
ALENDRONATE SODIUM 68 57 29 60
ROPINIROLE HCL 67 37 31 30
ALLOPURINOL 66 43 32 73
HYDROCHLOROTHIAZIDE 66 60 32 40
FLUTICASONE PROPIONATE 65 64 34 11
LANSOPRAZOLE 63 51 35 98
FENOFIBRATE 57 22 36 69
ATENOLOL 56 36 37 34
AMITRIPTYLINE HCL 51 38 R 38 110
CRESTOR 51 41 38 25
MONTELUKAST SODIUM 50 35 40 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.